AI in Oncology Analytical Solutions Market: Meeting the Challenges of Growing Cancer Prevalence
Dublin, April 01, 2024 (GLOBE NEWSWIRE) -- The "AI in Oncology For Analytical Solutions Global Market Report 2024" report has been added to * ResearchAndMarkets.com's* offering.
*Exponential Market Growth Anticipated Through 2028*
The AI in oncology for analytical solutions market is witnessing a substantial surge, with projections estimating its growth from $0.8 billion in 2023 to $1.07 billion in 2024, reflecting a robust compound annual growth rate (CAGR) of 34.5%. Factors contributing to this remarkable escalation include the broadening availability of healthcare data, increased awareness and acceptance, and significant advancements in AI technologies.
*Advancing Healthcare through AI-Driven Oncological Solutions*
As the healthcare industry continues to evolve, the adoption of AI in oncology for analytical solutions is rapidly increasing. In the forthcoming years, the market is slated to reach $3.47 billion by 2028 at a steady CAGR of 34.1%. The growth is driven by the expanding demand for personalized medicine, greater healthcare industry awareness, and the integration of multi-omics data for comprehensive healthcare solutions.
*Meeting the Challenges of Growing Cancer Prevalence*
The ongoing battle against cancer's rising prevalence is a key driving force behind the growth of AI applications in oncology. AI plays an instrumental role in providing individualized treatment plans, early disease detection, and improved patient outcomes through its ability to seamlessly analyze vast and complex volumes of health data.
*Technological Innovations in AI for Cancer Research & Patient Care*
The global market is observing significant advancements with established enterprises focusing on the development of novel AI technologies. These innovations aim to facilitate accelerated cancer research and optimized AI-based models for patient care, exemplified by the recent launch of a state-of-the-art real-world data platform in the United States.
*Strategic Acquisitions Shaping the Future of Oncological AI*
A prominent acquisition in late 2023 by an India-based medical research company aims to establish a premier healthcare learning and research network in the field of oncology. This move is directed towards providing enhanced quality reporting, access to leading-edge real-world data, and AI-powered solutions to hasten clinical trials.
*A Global Perspective on AI in Oncology Market Dynamics*
North America currently leads the regional market share in the AI in oncology analytical solutions sphere. However, the Asia-Pacific region is anticipated to emerge as the fastest-growing market in the forecast period. This global market analysis covers a swath of geographical regions, providing a comprehensive outlook on the trends shaping healthcare. The AI in oncology for analytical solutions market encompasses the provision of services such as consulting, implementation, training, imaging analysis, genomic interpretation, and drug discovery and development.
*A selection of companies mentioned in this report includes, but is not limited to:*
· IBM Watson Health
· NVIDIA Corporation
· Siemens Healthineers
· GE Healthcare
· Tempus
· DeepMind Health
· Paige.AI
· PathAI
· Aidoc
· Nucleai
· HeartFlow
· OWKIN
· SOPHiA Genetics
· Imagen Technologies
· Butterfly Network
· Atomwise
· Enlitic
· Inspirata
· 3Scan
· Zebra Medical Vision
· Ibex Medical Analytics
· Vuno Inc.
· Proscia
· Google Health
· Huiying Medical
For more information about this report visit https://www.researchandmarkets.com/r/2b4v39
*About ResearchAndMarkets.com*
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood,Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900